Porosity effects of natural latex (Hevea brasiliensis) on release of compounds for biomedical applications
Source abstract
Abstract
Natural rubber latex biomedical (NRLb) obtained from the rubber tree Hevea brasiliensis has shown great potential in biomedicine and biomaterial applications. NRLb has been utilized as a physical barrier against infectious agents and in the controlled release of drugs and extracts. In the present work, NRLb was polymerized in a lyophilizer using different volumes of water to control the resultant membrane porosity and characterized regarding the surface morphology, water vapour permeability (WVP), mechanical properties, haemolytic activity and cytotoxicity. The release of bovine serum albumin protein from the latex membranes was evaluated. Drug release rates increased with porosity and membranes were able to control protein release up to 12 h. In addition, WVP increased with the quantity of pores. The cell viability observed for the porous membrane was higher than that noted for conventional membranes. In summary, the porosity control of natural latex membranes can be used to modulate properties and make them suitable for biomedical applications, such as wound dressings, modulated gas-exchange membranes and controlled drug delivery systems.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Plant-Derived Bioactive Compounds · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biochemistry and Chemical Technology, Institute of Chemistry, UNESP – Universidade Estadual Paulista, Araraquara, Brazil
Bioprocess and Biotechnology Department – FCF, UNESP – Universidade Estadual Paulista, Araraquara, Brazil
Drugs and Pharmaceuticals Department – FCF, UNESP – Universidade Estadual Paulista, Araraquara, Brazil
Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico · Fundação de Amparo à Pesquisa do Estado de São Paulo
References (41)
Show source-provided references
1. 10.1590/S0103-9733200600040002110.1590/S0103-97332006000400021 ↗
2. 10.1016/j.colsurfa.2011.09.02110.1016/j.colsurfa.2011.09.021 ↗
3. 10.1590/S0004-2749200400010000510.1590/S0004-27492004000100005 ↗
4. Borges AF · ISRN Polym Sci · 2014 · 2014
5. 10.1002/jbm.a.v95a:310.1002/jbm.a.v95a:3 ↗
6. Frade M · Med Cutánea Ibero-Latino-Americana · 2006 · 34 · 133
7. Frade MC · Med Cutánea Ibero-Latino-Americana · 2004 · 32 · 157
8. 10.1002/(ISSN)1521-390010.1002/(ISSN)1521-3900 ↗
9. 10.1590/S1516-1439200900020002310.1590/S1516-14392009000200023 ↗
10. Kemp AR, Straitiff WG. Latex. US Patent 2,276,986. 1942 Mar 17.
11. Araújo S · 1993
12. 10.3923/jas.2007.3801.380510.3923/jas.2007.3801.3805 ↗
13. 10.1007/s10989-016-9523-y10.1007/s10989-016-9523-y ↗
14. Hasma H · J Nat Rubber Res · 1992 · 7 · 102
15. 10.1590/S1516-1439201000010001310.1590/S1516-14392010000100013 ↗
16. 10.1038/263797a010.1038/263797a0 ↗
17. 10.1016/j.ejps.2006.03.00510.1016/j.ejps.2006.03.005 ↗
18. 10.3109/03639045.2011.65086310.3109/03639045.2011.650863 ↗
19. 10.1016/j.ejpb.2007.04.00810.1016/j.ejpb.2007.04.008 ↗
20. 10.1016/S0041-0101(98)00133-010.1016/S0041-0101(98)00133-0 ↗
21. 10.1590/S0034-7094200300010001210.1590/S0034-70942003000100012 ↗
22. 10.1016/0032-3861(68)90035-910.1016/0032-3861(68)90035-9 ↗
23. Kovuttikulrangsie S · J Rubber Res · 1999 · 2 · 150
24. Kovuttikulrangsie S · J Sci Technol · 2004 · 27 · 337
25. 10.1002/jps.303046101410.1002/jps.3030461014 ↗
26. 10.1016/j.jconrel.2004.10.01210.1016/j.jconrel.2004.10.012 ↗
27. 10.1016/S0376-7388(00)85130-310.1016/S0376-7388(00)85130-3 ↗
28. 10.4028/www.scientific.net/AMR.844.49010.4028/www.scientific.net/AMR.844.490 ↗
29. 10.1016/j.memsci.2012.04.01710.1016/j.memsci.2012.04.017 ↗
30. 10.1016/j.cherd.2012.09.01110.1016/j.cherd.2012.09.011 ↗
31. 10.1007/s10856-012-4676-510.1007/s10856-012-4676-5 ↗
32. 10.1080/09205063.2015.108694510.1080/09205063.2015.1086945 ↗
33. ISO. Biological evaluation of medical devices. V. Tests for cytotoxicity: in vitro methods; Geneva, Switzerland: International Organization for Standardization, 2009; 10993–10995.
34. ISO. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials; Geneva, Switzerland: International Organization for Standardization, 2012;10993–12.
35. 10.1002/app.4532110.1002/app.45321 ↗
36. 10.1007/s10856-013-5089-910.1007/s10856-013-5089-9 ↗
37. 10.1590/S1516-1439200400020001010.1590/S1516-14392004000200010 ↗
38. 10.3349/ymj.2005.46.4.57910.3349/ymj.2005.46.4.579 ↗
39. Nakamura A · Biomaterials · 1990 · 11 · 92
40. 10.1088/1757-899X/11/1/01200210.1088/1757-899X/11/1/012002 ↗
41. 10.1007/s10856-014-5255-810.1007/s10856-014-5255-8 ↗